Schedule 13G ownership disclosure

Inhibrx Biosciences Inc

Common Stock · CUSIP: 45720N103

Event date: 2026-09-30

Filing-level shares
357,318.00
Percent of class
2.4%
  • BANK OF AMERICA CORP /DE/

    Shares: 357,318.00 · Class: 2.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000070858-26-000526
Form type
SCHEDULE 13G/A
Filer
Inhibrx Biosciences, Inc.
CIK
CIK 2007919
Filed
Oct 28, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub